Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. / Wong, D F; Pearlson, G D; Tune, L E; Young, L T; Meltzer, C C; Dannals, R F; Ravert, H T; Reith, J; Kuhar, M J; Gjedde, A.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 17, No. 3, 1997, p. 331-42.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Wong, DF, Pearlson, GD, Tune, LE, Young, LT, Meltzer, CC, Dannals, RF, Ravert, HT, Reith, J, Kuhar, MJ & Gjedde, A 1997, 'Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.', Journal of Cerebral Blood Flow and Metabolism, vol. 17, no. 3, pp. 331-42. https://doi.org/10.1097/00004647-199703000-00010

APA

Wong, D. F., Pearlson, G. D., Tune, L. E., Young, L. T., Meltzer, C. C., Dannals, R. F., Ravert, H. T., Reith, J., Kuhar, M. J., & Gjedde, A. (1997). Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. Journal of Cerebral Blood Flow and Metabolism, 17(3), 331-42. https://doi.org/10.1097/00004647-199703000-00010

Vancouver

Wong DF, Pearlson GD, Tune LE, Young LT, Meltzer CC, Dannals RF et al. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. Journal of Cerebral Blood Flow and Metabolism. 1997;17(3):331-42. https://doi.org/10.1097/00004647-199703000-00010

Author

Wong, D F ; Pearlson, G D ; Tune, L E ; Young, L T ; Meltzer, C C ; Dannals, R F ; Ravert, H T ; Reith, J ; Kuhar, M J ; Gjedde, A. / Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. In: Journal of Cerebral Blood Flow and Metabolism. 1997 ; Vol. 17, No. 3. pp. 331-42.

Bibtex

@article{2eb73fa0b31511debc73000ea68e967b,
title = "Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.",
abstract = "In a previous study of 10 drug-naive schizophrenic patients, the density of D2 dopamine receptors was found to be elevated in the caudate nucleus. The study raised questions about the influence of the age of the patients, the relationship of receptor density to psychosis, and the accuracy of the method used to obtain this evidence. Using positron emission tomography and constrained analysis of the brain uptake of the radioligand N-[11C]methyl-spiperone ([11C]NMSP), we tested four questions: Were the assumptions underlying the quantitation valid? Is there an age decline of the density of D2-like dopamine receptors in drug-naive schizophrenia and bipolar illness? If so, is it different from that observed in normal aging? Are D2-like dopamine receptors elevated at any age in either drug-naive schizophrenic or psychotic bipolar illness patients? NMSP and haloperidol partition volumes and plasma protein fractions were not significantly different among patient groups and normal volunteers. The model-derived assay of radioligand metabolites in plasma was confirmed by high-performance liquid chromatography in the patient groups. D2-like dopamine receptors declined with age, and the slope did not differ significantly between the schizophrenic patients, bipolar affective illness patients, and normal controls. Taking the effect of age into account, increases in D2 dopamine receptor density were found in seven psychotic patients with bipolar affective illness compared with seven nonpsychotic patients and 24 control subjects as well as in 22 drug-naive schizophrenic patients compared with the 24 control subjects.",
author = "Wong, {D F} and Pearlson, {G D} and Tune, {L E} and Young, {L T} and Meltzer, {C C} and Dannals, {R F} and Ravert, {H T} and J Reith and Kuhar, {M J} and A Gjedde",
year = "1997",
doi = "10.1097/00004647-199703000-00010",
language = "English",
volume = "17",
pages = "331--42",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "SAGE Publications",
number = "3",

}

RIS

TY - JOUR

T1 - Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.

AU - Wong, D F

AU - Pearlson, G D

AU - Tune, L E

AU - Young, L T

AU - Meltzer, C C

AU - Dannals, R F

AU - Ravert, H T

AU - Reith, J

AU - Kuhar, M J

AU - Gjedde, A

PY - 1997

Y1 - 1997

N2 - In a previous study of 10 drug-naive schizophrenic patients, the density of D2 dopamine receptors was found to be elevated in the caudate nucleus. The study raised questions about the influence of the age of the patients, the relationship of receptor density to psychosis, and the accuracy of the method used to obtain this evidence. Using positron emission tomography and constrained analysis of the brain uptake of the radioligand N-[11C]methyl-spiperone ([11C]NMSP), we tested four questions: Were the assumptions underlying the quantitation valid? Is there an age decline of the density of D2-like dopamine receptors in drug-naive schizophrenia and bipolar illness? If so, is it different from that observed in normal aging? Are D2-like dopamine receptors elevated at any age in either drug-naive schizophrenic or psychotic bipolar illness patients? NMSP and haloperidol partition volumes and plasma protein fractions were not significantly different among patient groups and normal volunteers. The model-derived assay of radioligand metabolites in plasma was confirmed by high-performance liquid chromatography in the patient groups. D2-like dopamine receptors declined with age, and the slope did not differ significantly between the schizophrenic patients, bipolar affective illness patients, and normal controls. Taking the effect of age into account, increases in D2 dopamine receptor density were found in seven psychotic patients with bipolar affective illness compared with seven nonpsychotic patients and 24 control subjects as well as in 22 drug-naive schizophrenic patients compared with the 24 control subjects.

AB - In a previous study of 10 drug-naive schizophrenic patients, the density of D2 dopamine receptors was found to be elevated in the caudate nucleus. The study raised questions about the influence of the age of the patients, the relationship of receptor density to psychosis, and the accuracy of the method used to obtain this evidence. Using positron emission tomography and constrained analysis of the brain uptake of the radioligand N-[11C]methyl-spiperone ([11C]NMSP), we tested four questions: Were the assumptions underlying the quantitation valid? Is there an age decline of the density of D2-like dopamine receptors in drug-naive schizophrenia and bipolar illness? If so, is it different from that observed in normal aging? Are D2-like dopamine receptors elevated at any age in either drug-naive schizophrenic or psychotic bipolar illness patients? NMSP and haloperidol partition volumes and plasma protein fractions were not significantly different among patient groups and normal volunteers. The model-derived assay of radioligand metabolites in plasma was confirmed by high-performance liquid chromatography in the patient groups. D2-like dopamine receptors declined with age, and the slope did not differ significantly between the schizophrenic patients, bipolar affective illness patients, and normal controls. Taking the effect of age into account, increases in D2 dopamine receptor density were found in seven psychotic patients with bipolar affective illness compared with seven nonpsychotic patients and 24 control subjects as well as in 22 drug-naive schizophrenic patients compared with the 24 control subjects.

U2 - 10.1097/00004647-199703000-00010

DO - 10.1097/00004647-199703000-00010

M3 - Journal article

C2 - 9119906

VL - 17

SP - 331

EP - 342

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 3

ER -

ID: 14945698